仙琚制药：雌二醇片/雌二醇地屈孕酮片复合包装药品注册申请获受理

Core Viewpoint - Xianju Pharmaceutical (002332) has received a drug registration acceptance notice from the National Medical Products Administration for the combined packaging of estradiol tablets and estradiol-dydrogesterone tablets, indicating progress in its product development and regulatory approval process [1] Group 1 - The company announced the receipt of a drug registration acceptance notice for estradiol tablets and estradiol-dydrogesterone tablets [1] - The specifications of the combined packaging submitted by the company are consistent with those of the original approved products [1] - The application is classified under Category 4 of chemical drugs [1]